Scolaris Content Display Scolaris Content Display

Rehabilitación multidisciplinaria después del tratamiento del tumor cerebral primario

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Khan 2014 {published data only}

Khan F, Amatya B, Drummond K, Galea M. Effectiveness of integrated multidisciplinary rehabilitation in primary brain cancer survivors in an Australian community cohort: a controlled clinical trial. Journal of Rehabilitation Medicine 2014;46:754‐60. CENTRAL

References to studies excluded from this review

Bartolo 2012 {published data only}

Bartolo M, Zucchella C, Pace A, Lanzetta G, Vecchione C, Bartolo M, et al. Early rehabilitation after surgery improves functional outcome in inpatients with brain tumours. Journal of Neuro‐Oncology 2012;107:537‐44. CENTRAL

Chan 2013 {published data only}

Chan V, Zagorski B, Parsons D, Colantonio A. Older adults with acquired brain injury: outcomes after inpatient rehabilitation. Canadian Journal of Aging 2013;32(3):278‐86. CENTRAL

Cohen 2002 {published data only}

Cohen HS, Kimball KT, Jenkins HA. Factors affecting recovery after acoustic neuroma resection. Acta Otolaryngology 2002;122:841‐51. CENTRAL

Fu 2010 {published data only}

Fu JB, Parsons HA, Shin KY, Guo Y, Konzen BS, Yadav RR, et al. Comparison of functional outcomes in low‐ and high‐grade astrocytoma rehabilitation inpatients. American Journal of Physical Medicine and Rehabilitation 2010;89(3):205‐12. CENTRAL

Gehring 2009 {published data only}

Gehring K, Sitskoorn MM, Gundy CM, Sikkes SAM, Klein M, Postma TJ, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. Journal of Clinical Oncology 2009;27(22):3712‐22. CENTRAL

Geler‐Kulcu 2009 {published data only}

Geler‐Kulcu D, Gulsen G, Buyukbaba E, Ozkan D. Functional recovery of patients with brain tumor or acute stroke after rehabilitation: a comparative study. Journal of Clinical Neuroscience 2009;16(1):74‐8. CENTRAL

Greenberg 2006 {published data only}

Greenberg E, Treger I, Ring H. Rehabilitation outcomes in patients with brain tumors and acute stroke: comparative study of inpatient rehabilitation. American Journal of Physical Medicine and Rehabilitation 2006;85(7):568‐73. CENTRAL

Huang 1998 {published data only}

Huang ME, Cifu DX, Keyser‐Marcus L. Functional outcome after brain tumor and acute stroke: a comparative analysis. Archives of Physical Medicine and Rehabilitation 1998;79(11):1386‐90. CENTRAL

Huang 2000 {published data only}

Huang ME, Cifu DX, Keyser‐Marcus L. Functional outcomes in patients with brain tumor after inpatient rehabilitation: comparison with traumatic brain injury. American Journal of Physical Medicine and Rehabilitation 2000;79(4):327‐35. CENTRAL

Huang 2001a {published data only}

Huang ME, Wartella JE, Kreutzer JS. Functional outcomes and quality of life in patients with brain tumors: a preliminary report. Archives of Physical Medicine and Rehabilitation 2001;82(11):1540‐6. CENTRAL

Jensen 2014 {published data only}

Jensen W, Bialy L, Ketels G, Baumann FT, Bokemeyer C, Oechsle K. Physical exercise and therapy in terminally ill cancer patients: a retrospective feasibility analysis. Support Care Cancer 2014;22(5):1261‐8. CENTRAL

Kawahira 2004 {published data only}

Kawahira K, Shimodozono M, Ogata A, Tanaka N. Addition of intensive repetition of facilitation exercise to multidisciplinary rehabilitation promotes motor functional recovery of the hemiplegic lower limb. Journal of Rehabilitation Medicine 2004;36(4):159‐64. CENTRAL

Kim 2012 {published data only}

Kim BR, Chun MH, Han EY, Kim DK. Fatigue assessment and rehabilitation outcomes in patients with brain tumors. Support Care Cancer 2012;20(4):805‐12. CENTRAL

Marciniak 1996 {published data only}

Marciniak CM, Sliwa JA, Spill G, Heinemann AW, Semik PE. Functional outcomes following rehabilitation of the cancer patients. Archives of Physical Medicine and Rehabilitation 1996;77:54‐7. CENTRAL

Marciniak 2001 {published data only}

Marciniak CM, Sliwa JA, Heinemann AW, Semik PE. Functional outcomes of persons with brain tumors after inpatient rehabilitation. Archives of Physical Medicine and Rehabilitation 2001;82(4):457‐63. CENTRAL

O'Dell 1998 {published data only}

O'Dell MW, Barr K, Spanier D, Warnick RE. Functional outcome of inpatient rehabilitation in persons with brain tumors. Archives of Physical Medicine and Rehabilitation 1998;79(12):1530‐4. CENTRAL

Pace 2007 {published data only}

Pace A, Parisi C, Di Lelio M, Zizzari A, Petreri G, Giovannelli M, et al. Home rehabilitation for brain tumor patients. Journal of Experimental & Clinical Cancer Research 2007;26(3):297‐300. CENTRAL

Piil 2013 {published data only}

Piil K, Jarden M, Jakobsen J, Christensen KB, Juhler M. A longitudinal, qualitative and quantitative exploration of daily life and need for rehabilitation among patients with high‐grade gliomas and their caregivers. BMJ Open 2013;3(7):e003183. CENTRAL

Rummans 2006 {published data only}

Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, et al. Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: A randomized controlled trial. Journal of Clinical Oncology 2006;24(4):635‐42. CENTRAL

Sherer 1997 {published data only}

Sherer M, Meyers CA, Bergloff P. Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer 1997;2:250‐7. CENTRAL

Tang 2008 {published data only}

Tang V, Rathbone M, Park Dorsay J, Jiang S, Harvey D. Rehabilitation in primary and metastatic brain tumours: impact of functional outcomes on survival. Journal of Neurology 2008;255(6):820‐7. CENTRAL

Vereeck 2008 {published data only}

Vereeck L, Wuyts FL, Truijen S, De Valck C, Van de Heyning PH. The effect of early customized vestibular rehabilitation on balance after acoustic neuroma resection. Clinical Rehabilitation 2008;22(8):698‐713. CENTRAL

Zucchella 2013 {published data only}

Zucchella C, Capone A, Codella V, De Nunzio AM, Vecchione C, Sandrini G, et al. Cognitive rehabilitation for early post‐surgery inpatients affected by primary brain tumor: a randomized, controlled trial. Journal of Neuro‐Oncology 2013;114(1):93‐100. CENTRAL

Additional references

Andrews 2004

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. The Lancet 2004;363:1665‐72.

Arber 2010

Arber A, Faithfull S, Plaskota M, Lucas C, de Vries K. A study of patients with a primary malignant brain tumour and their carers: symptoms and access to services. International Journal of Palliative Nursing 2010;16(1):24‐30.

AROC 2011

Australasian Rehabilitation Outcome Centre (AROC). AROC Inpatient Clinical Data Set. Australasian Faculty of Rehabilitation Medicine (AFRM), University of Wollongong2011; Vol. Available from: http://ahsri.uow.edu.au/aroc/dataset/index.html.

Aziz 2003

Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: challenge and opportunity. Seminars in Radiation Oncology 2003;13(3):248–66.

Boake 1993

Boake C, Meyers CA. Brain tumor rehabilitation: survey of clinical practice (Abstract). Archives of Physical Medicine and Rehabilitation 1993;74:1247.

Brain Foundation 2011

Brain tumour and brain cancer, Australia. Brain Foundation2011:Available from: http://brainfoundation.org.au/brain‐tumour.

Campbell 1999

Campbell ML, Sheets D, Strong PS. Secondary health conditions among middle aged individuals with chronic physical disabilities: implications for unmet needs for services. Assistive Technology 1999;11(2):105‐22.

Cancer Reform Strategy 2007

Department of Health. Cancer Reform Strategy. www.dh.gov.uk/en/Healthcare/NationalServiceFrameworks/Cancer/index.htm2007; Vol. (accessed: 14 May 2015).

Chandana 2008

Chandana SR, Movva S, Arora M, Singh T. Primary brain tumors in adults. American Family Physician 2008;77:1423‐30.

Cieza 2008

Cieza A, Stucki G. The International Classification of Functioning Disability and Health: its development process and content validity. European Journal of Physical Rehabilitation Medicine 2008;44(3):303‐13.

Corner 2007

Corner J, Richardson A. Cancer Survivorship Briefing Paper. http://www.macmillan.org.uk/Documents/Support_Material/Get_involved/Campaigns/ca2007; Vol. (accessed 14 May 2015).

Department of Health 2013

Department of Health. Living with and beyond cancer: taking action to improve outcomes. National Cancer Survivorship Initiative (NCSI), UK: Link: http://www.ncsi.org.uk/wp‐content/uploads/Living‐with‐and‐beyond‐2013.pdf. London, 2013.

Dietz 1969

Dietz JH. Rehabilitation of the cancer patient. Medical Clinics of North America 1969;53:607‐24.

Egger 1998

Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998;16(7124):61‐6.

Fisk 1994

Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical Infectious Disease 1994;18(Suppl 1):S79‐83.

Flowers 2000

Flowers A. Brain tumors in the older person. Cancer Control 2000;7(6):523‐38.

Franklin 2007

Franklin DJ. Cancer rehabilitation: challenges, approaches, and new directions. Physical Medicine and Rehabilitation Clinics of North America 2007;18:899‐924.

Gabanelli 2005

Gabanelli P. A rehabilitative approach to the patient with brain cancer. Neurological Sciences 2005;26(Suppl 1):S51‐2.

Ganz 1992

Ganz PA, Schag CA, Lee TJ, Sims MS. The CARES: a generic measure of health related quality of life for patients with cancer. Quality of Life Research 1992;1:19‐29.

Gilworth 2003

Gilworth G, Chamberlain MA, Harvey A. Development of a work instability scale for rheumatoid arthritis. Arthritis and Rheumatism 2003;49:349‐54.

Goetzsche 1987

Goetzsche PC. Reference bias in reports of drug trials. BMJ 1987;295:654‐6.

Granger 1998

Granger CV. The emerging science of functional assessment: our tool for outcomes analysis. Archives of Physical Medicine and Rehabilitation 1998;79:235‐40.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from: www.cochrane‐handbook.org. The Cochrane Collaboration.

Hodgkinson 2007

Hodgkinson K, Butow P, Hunt G, Pendlebury S, Hobbs K, Wain G. Breast cancer survivors supportive care needs 2‐10 years after diagnosis. Supportive Care in Cancer 2007;15:515‐23.

Horn 2012

Horn SD, DeJong G, Deutscher D. Practice‐based evidence research in rehabilitation: an alternative to randomized controlled trials and traditional observational studies. Archives of Physical Medicine and Rehabilitation 2012;93(Suppl 2):S127‐37.

Huang 2001b

Huang ME, Wartella J, Kreutzer J, Broaddus W, Lyckholm L. Functional outcomes and quality of life in patients with brain tumours: a review of the literature. Brain Injury 2001;15:843‐56.

Huang 2011

Huang ME, Silwa JA. Inpatients rehabilitation of patients with cancer: efficacy and treatment consideration. Physical Medicine and Rehabilitation 2011;3:746‐57.

Jemal 2009

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA: Cancer Journal for Clinicians 2009;59(4):225‐49.

Khan 2007

Khan F, Turner‐Stokes L, Ng L, Kilpatrick T, Amatya B. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006036.pub2]

Khan 2009

Khan F, Turner Stokes L, Stevermuer T, Simmonds F. Multiple sclerosis rehabilitation outcomes: analysis of a national casemix data set from Australia. Multiple Sclerosis 2009;15:869‐75.

Khan 2010

Khan F, Ng L, Amatya B, Brand C, Turner‐Stokes L. Multidisciplinary care for Guillain‐Barré syndrome. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD008505.pub2]

Khan 2011

Khan F, Amatya B, Ng L, Turner‐Stokes L, Drummond K. Multidisciplinary rehabilitation for follow‐up after primary brain tumour treatment. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD009509]

Khan 2012a

Khan F, Amatya B, Pallant JF, Rajapaksa I, Brand C. Multidisciplinary rehabilitation in women following breast cancer treatment: a randomized controlled trial. Journal of Rehabilitation Medicine 2012;44:788‐94.

Khan 2012b

Khan F, Amatya B, Ng L, Demetrios M, Zhang N, Turner‐Stokes L. Multidisciplinary rehabilitation for follow‐up of women treated for breast cancer. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD009553.pub2]

Khan 2013a

Khan F, Amatya B, Ng L, Drummond K, Olver J. Multidisciplinary rehabilitation after primary brain tumour treatment. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD009509.pub2]

Khan 2013b

Khan F, Amatya B. Use of the International Classification of Functioning, Disability and Health (ICF) to describe patient‐reported disability in primary brain tumour in an Australian community cohort. Journal of Rehabilitation Medicine 2013;45:434‐45.

Khan 2013c

Khan F, Amatya B. Factors associated with long‐term functional outcomes, psychological sequelae and quality of life in persons after primary brain tumour. Journal of Neuro‐Oncology 2013;111:355‐66.

Khan 2013d

Khan F, Amatya B, Rajapaksa I, Ng L. Outcomes of social support programs in brain cancer survivors in an Australian community cohort: a prospective study. Journal of Cancer Research and Therapy 2013;1(1):24‐33.

Kirshblum 2001

Kirshblum S, O'Dell MW, Ho C, Barr K. Rehabilitation of persons with central nervous system tumors. Cancer 2001;92(Suppl 4):1029‐38.

Leib 2011

Leib A, Cieza A, Tschiesner U. Perspective of physicians within a multidisciplinary team: Content validation of the comprehensive ICF core set for head and neck cancer. Head and Neck2011 [Epub ahead of print]. [DOI: 10.1002/hed.21844]

Louis 2007

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathology 2007;114:97‐109.

Lovibond 1995

Lovibond SH, Lovibond PF. Manual for the Depression Anxiety Stress Scales (DASS). Sydney: Psychology Foundation of Australia, 1995.

MacVicar 1986

MacVicar MG, Winningham ML. Promoting functional capacity of cancer patients. Cancer Bulletin 1986;38:235‐9.

MacVicar 1989

MacVicar MG, Winningham ML, Nickel JL. Effects of aerobic interval training on cancer patients' functional capacity. Nursing Research 1989;38:348‐51.

Mahoney 1965

Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Medical Journal 1965;14:56‐61.

Markes 2006

Markes M, Brockow T, Resch KL. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD005001.pub2]

McNeely 2010

McNeely ML, Campbell K, Opsina M, Rowe BH, Dabbs K, Klassen TP, et al. Exercise interventions for upper‐limb dysfunction due to breast cancer treatment. Cochrane Database of Systematic Reviews 2010, Issue 6. [DOI: 10.1002/14651858.CD005211.pub2]

MRC 2000

Medical Research Council. A framework for development and evaluation of RCTs for complex interventions to improve health. London: MRC2000.

NCCS 2009

NCCS. National Coalition for Cancer Survivorship. http://www.canceradvocacy.org/2009; Vol. (accessed 14 May 2015).

Ness 2010

Ness KK, Morris EB, Nolan VG, Howell CR, Gilchrist LS, Stovall M, et al. Physical performance limitations among adult survivors of childhood brain tumors. Cancer 2010;116(12):3034‐44.

Ng 2009

Ng L, Khan F, Mathers S. Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007425.pub2]

Ownsworth 2009

Ownsworth T, Hawkes A, Steginga S, Walker D, Shum D. A biopsychosocial perspective on adjustment and quality of life following brain tumor: a systematic evaluation of the literature. Disability and Rehabilitation 2009;31(13):1038‐55.

O’Dell 1998

O’Dell MW, Barr K, Spanier D, Warnick RE. Functional outcome of inpatient rehabilitation in persons with brain tumors. Archives of Physical Medicine and Rehabilitation 1998;79(2):1530‐4.

Pallant 2006

Pallant JF, Misajon R, Bennett E, Manderson L. Measuring the impact and distress of health problems from the individual's perspective: development of the Perceived Impact of Problem Profile (PIPP). Health and Quality of Life Outcomes 2006;4(1):36.

Parkin 2005

Parkin DM, Whelan SL, Ferlay J. Cancer incidence in five continents, vol. I to VIII. IARC Cancerbase No 72005:Lyon.

Pirzkall 1998

Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart‐Cabillic R, et al. Radiosurgery alone or in combination with whole‐brain radiotherapy for brain metastases. Journal of Clinical Oncology 1998;16:3563‐9.

Poggi 2009

Poggi G, Liscio M, Pastore V, Adduci A, Galbiati S, Spreafico F, et al. Psychological intervention in young brain tumor survivors: the efficacy of the cognitive behavioural approach. Disability and Rehabilitation 2009;31(13):1066‐73.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Schag 1991

Schag CA, Ganz PA, Heinrich RL. Cancer rehabilitation evaluation system‐short form (CARES‐SF). Cancer 1991;68:1406‐13.

Sheard 1999

Sheard T, Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta analyses. British Journal of Cancer 1999;80:1770‐80.

Sherwood 2006

Sherwood PR, Given BA, Given CW, Schiffman RF, Murman DL, Lovely M, et al. Predictors of distress in caregivers of persons with a primary malignant brain tumor. Research in Nursing Health 2006;29:105‐20.

Stewart 2002

Stewart L, Burdett S, Glioma Meta‐analysis Trialists Group (GMT). Chemotherapy for high‐grade glioma. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003913]

SUTC 2007

Stroke Unit Trialists' Collaboration (SUTC). Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD000197.pub2]

Tschiesner 2010a

Tschiesner U, Rogers S, Dietz A, Yueh B, Cieza A. Development of ICF core sets for head and neck cancer. Head and Neck 2010;32:210‐20.

Tschiesner 2010b

Tschiesner U, Linseisen E, Becker S, Mast G, Rogers SN, Walvekar RR, et al. Content validation of the international classification of functioning, disability and health core sets for head and neck cancer: a multicentre study. Journal of Otolaryngology, Head and Neck Surgery 2010;39:674‐87.

Turk 2001

Turk MA, Scandale J, Rosenbaum PF, Weber RJ. The health of women with cerebral palsy. Physical Medicine and Rehabilitation Clinics of North America 2001;12(1):153‐68.

Turner Stokes 2005

Turner Stokes L, Nair A, Sedki I, Disler PB, Wade DT. Multidisciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004170.pub2]

van Tulder 2003

van Tulder MW, Furlan A, Bombardier C, Bouter L. Updated method guidelines for systematic reviews in The Cochrane Collaboration Back Review Group. Spine 2003;28(12):1290‐9.

Vargo 2011

Vargo M. Brain tumor rehabilitation. American Journal of Physical Medicine and Rehabilitation 2011;90:S50‐62.

Wade 1992

Wade DT. Measurement in Neurological Rehabilitation. Oxford: Oxford University Press, 1992.

Ware 1993

Ware JE, Snow KK, Kosinski M, Gandek B. SF‐36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.

WHO 2001

World Health Organization (WHO). International Classification of Functioning Disability and Health (ICF). Geneva: WHO, 2001.

Whyte 2002

Whyte J. Traumatic brain injury rehabilitation: are there alternatives to randomized clinical trials?. Archives of Physical Medicine and Rehabilitation 2002;83(9):1320‐2.

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Khan 2014

Methods

Controlled clinical trial

Participants

Australia. N = 106 (with gliomas): treatment group = 53, control group= 53

Demographic characteristics:

Intervention group: age: mean 53.1 +/‐ 13.3, range 21 to 77 years; female 59%; married/partner: 77%; disease duration (median 2.3, interquartile range:‐ 0.8, 5.5 years)

Control group: age: mean 50.0 +/‐ 13.8, range 28 to 74 years; female 57%; married/partner: 76%; disease duration (median 1.9, interquartile range:‐ 0.8, 3.8 years)

Inclusion criteria: aged ≥ 18 years; fulfilled criteria for BT grading system (grade I to IV) for gliomas as outlined by the WHO for Central Nervous System Tumours; stable medical course, post BT surgery, radiotherapy, and/or chemotherapy, assessed by a rehabilitation physician/neurosurgeon for presence of neurological deficits and ability to participate in therapy up to 2.5 hours of interrupted therapy/day; and the clinical judgement of the assessing rehabilitation team; resided in the community (area of greater Melbourne < 60 km radius); able to communicate in English

Exclusion criteria: those diagnosed with benign or metastatic BTs, significant comorbidities or medically unstable, or psychiatric disorders (such as uncontrolled schizophrenia, actively suicidal/self harm, or physically aggressive (based on clinical judgement)) limiting participation in rehabilitation, those bed‐bound or institutionalised in nursing homes or both

Interventions

Treatment group: individualised high‐intensity outpatient multidisciplinary rehabilitation programme, up to 3 one‐hour sessions of interrupted therapy/week, comprising half‐hour blocks of therapy sessions (occupational, social, psychological, and physiotherapy), 2 to 3 times per week for 6 to 8 weeks

Control group: wait‐list with usual outpatient care (offered treatment poststudy)

Outcomes

Measures for activity: FIM
Measures for participation: DASS, CARES‐SF, PIPP

Assessment time points: baseline, 3 months, and 6 months

Notes

Single‐centre study

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

High risk

Participants not randomised to the treatment or control group

Allocation concealment (selection bias)

High risk

No allocation concealment

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Participants were not blinded, as the rehabilitation intervention itself requires participants to be consented for treatment, hence making it difficult to blind participants. This could have influenced participant‐reported outcomes. However, participants were asked not to discuss their involvement in the study with treating therapists and outcome assessors in order to reduce the risk of breaking blinding of the therapists and assessors. Treating therapists were blinded.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Outcome assessors were blinded. See row above for further explanation

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Overall, 21 participants (20%) dropout at 6‐months follow‐up: 12 in the intervention group and 9 in the control group

(8 participants (7%) dropout at 3‐months follow‐up: 4 in each group)

Selective reporting (reporting bias)

Low risk

All prespecified (primary and secondary) outcomes reported.

Other bias

Unclear risk

  • Poor generalisability: single institution, not representative of all Australian people

  • Potential source of bias related to the study design

  • No long‐term follow‐up

  • Avoidance of co‐interventions or their equal distribution throughout study groups was not reported. Reporting of co‐interventions could have helped judgement of their division among study groups, and whether they would have significantly affected the outcome

  • Size of study: unclear risk (50 to 199 participants)

BT: brain tumour
CARES‐SF: Cancer Rehabilitation Evaluation System‐Short Form
DASS: Depression Anxiety Stress Scales
FIM: Functional Independence Measure
PIPP: Perceived Impact of Problem Profile
WHO: World Health Organization

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Bartolo 2012

Not RCT or CCT

Chan 2013

Not RCT or CCT. Details of brain tumour subgroup not provided

Cohen 2002

Uni‐disciplinary ‐ physical therapy

Fu 2010

Not RCT or CCT

Gehring 2009

Unidisciplinary ‐ psychological intervention

Geler‐Kulcu 2009

Not RCT or CCT

Greenberg 2006

Not RCT or CCT

Huang 1998

Not RCT or CCT

Huang 2000

Not RCT or CCT

Huang 2001a

Not RCT or CCT

Jensen 2014

Unidisciplinary ‐ physical therapy

Kawahira 2004

Not RCT or CCT

Kim 2012

Not RCT or CCT

Marciniak 1996

Not RCT or CCT

Marciniak 2001

Not RCT or CCT

O'Dell 1998

Not RCT or CCT

Pace 2007

Not RCT or CCT

Piil 2013

Not RCT or CCT

Rummans 2006

Details of brain tumour subgroup not provided

Sherer 1997

Not RCT or CCT

Tang 2008

Not RCT or CCT

Vereeck 2008

Unidisciplinary ‐ physical therapy

Zucchella 2013

Unidisciplinary ‐ psychological intervention

CCT: controlled clinical trial
RCT: randomised controlled trial

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

High‐intensity multidisciplinary rehabilitation compared with wait‐list control group with usual care for primary brain tumour

Patient or population: 106 participants with primary brain tumour

Settings: outpatient

Intervention: High‐intensity multidisciplinary rehabilitation

Comparison: wait‐list control group with usual care

Outcomes

Illustrative comparative risks*

Relative effect*
(Effect size 'R')#

No of Participants
(studies)

Quality of the evidence
(GRADE)1

Comments

Assumed risk

Corresponding risk

Usual care (control group)

High‐intensity multidisciplinary rehabilitation (intervention group)

Short‐term disability outcomes at 3‐months postintervention

Change in short‐term disability (function)

FIM motor

Median change = 8 points higher

Median change = 18 points higher

Z score: ‐3.13,

P < 0.001

R: 0.32

106

(1 study)

⊕⊕⊕⊕

Low1

13 items with 4 subscales (self care, transfers, locomotion, sphincter control, assessing function (activity) and need for assistance, rated on a 7‐point scale (1‐7), with higher score indicating higher independence and lower need for assistance

Change in short‐term disability (cognition)

FIM cognition

Median change = 3 points higher

Median change = 6 points higher

Z score: ‐1.99,

P < 0.05

R: 0.20

106

(1 study)

⊕⊕⊕⊕

Low1

3 items with 3 subscales (communication, psychological, cognition) assessing cognition, rated on a 7‐point scale (1‐7), with higher score indicating higher independence and lower need for assistance

Long‐term disability outcomes at 6‐months postintervention

Change in long‐term disability (function)

FIM motor

Median change = 4 points higher

Median change = 12 points higher

Z score: ‐2.33,

P < 0.05

R: 0.25

106

(1 study)

⊕⊕⊕⊕

Low1

13 items with 4 subscales (self care, transfers, locomotion, sphincter control, assessing function (activity) and need for assistance, rated on a 7‐point scale (1‐7), with higher score indicating higher independence and lower need for assistance

Change in long‐term disability (cognition)

FIM cognition

Median change = 1.5 points higher

Median change = 6 points higher

Z score: ‐3.09,

P < 0.001

R: 0.20

106

(1 study)

⊕⊕⊕⊕

Low1

3 items with 3 subscales (communication, psychological, cognition) assessing cognition, rated on a 7‐point scale (1‐7), with higher score indicating higher independence and lower need for assistance

Change in short‐term participation outcomes at 3‐months postintervention

Change in short‐term psychological outcomes
DASS (total)

Median change = 12 points lower

Median change = 8 points lower

Z score: ‐0.53,

P > 0.05

R: 0.05

106

(1 study)

⊕⊕⊕⊕

Low1

21 items with 3 subscales assessing depression, anxiety, and stress, rated on a 4‐point scale, with higher score indicating higher level of impairment

Change in short‐term participation
PIPP (total)

Median change = 7 points lower

Median change = 6 points lower

Z score: ‐0.40,

P > 0.05

R: 0.04

106

(1 study)

⊕⊕⊕⊕

Low1

23 items with 5 subscales assessing mobility, self care, relationships, participation, and psychological well‐being, rated on a 6‐point scale, with high scores indicating greater impact

Change in short‐term QoL

CARES‐SF (global)

Median change = 0.2 points lower

Median change = 0.1 points lower

Z score: ‐0.10,

P > 0.05

R: 0.01

106

(1 study)

⊕⊕⊕⊕

Low1

59‐item global scale, with overall score indicating QoL and summary scores for the 5 domains (physical, psychosocial, medical interaction, marital and sexual function), assessing cancer‐specific rehabilitation need and QoL, rated on a 4‐point scale, with higher scores indicating more difficulty or lower QoL

Change in long‐term participation outcomes at 6‐months postintervention

Change in long‐term psychological outcomes
DASS (total)

Median change = 10 points lower

Median change = 12 points lower

Z score: ‐0.98,

P > 0.05

R: 0.11

106

(1 study)

⊕⊕⊕⊕

Low1

21 items with 3 subscales assessing depression, anxiety, and stress, rated on a 4‐point scale, with higher score indicating higher level of impairment

Change in long‐term participation
PIPP (total)

Median change = 9.5 points higher

Median change = 5 points lower

Z score: ‐0.37,

P > 0.05

R: 0.04

106

(1 study)

⊕⊕⊕⊕

Low1

23 items with 5 subscales assessing mobility, self care, relationships, participation, and psychological well‐being, rated on a 6‐point scale, with high scores indicating greater impact

Change in long‐term QoL

CARES‐SF (global)

Median change = 0.2 points lower

Median change = 0.2 points lower

Z score: ‐0.42,

P < 0.05

R: 0.05

106

(1 study)

⊕⊕⊕⊕

Low1

59‐item global scale, with overall score indicating QoL and summary scores for the 5 domains (physical, psychosocial, medical interaction, marital and sexual function), assessing cancer‐specific rehabilitation need and QoL, rated on a 4‐point scale, with higher scores indicating more difficulty or lower QoL

Change in other outcomes

Cost‐ effectiveness

See comment

See comment

Not estimable

106

(1 study)

See comment

Not measured

Serious adverse events

See comment

See comment

Not estimable

106
(1 study)

See comment

No serious adverse events attributed to the intervention

*Mann‐Whitney U tests

# Effect size statistics (R) were calculated and assessed against Cohen’s criteria (0.1 = small, 0.3 = medium, 0.5 = large effect)

CARES‐SF: Cancer Rehabilitation Evaluation System‐Short Form; DASS: Depression Anxiety Stress Scales; FIM: Functional Independence Measure; PIPP: Perceived Impact of Problem Profile; QoL: quality of life

1GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

Figuras y tablas -
Table 1. Characteristics of observational studies

Bartolo 2012

Methods

Case‐control study, Italy

Participants

N = 150; Intervention: N = 75 with brain tumours (meningioma and glioblastoma), control: N = 75 with stroke

 

Inclusion: all admitted patients to an inpatient neurorehabilitation unit after surgery for brain tumours (meningiomas or glioblastomas) over a 2‐year period (2007‐2009). Control participants were stroke patients (ischaemic or haemorrhagic), matched one‐to‐one for age, sex, and side of lesion

Exclusion: people with oligoastrocytoma, oligodendroglioma, and ependymomas in order to obtain homogenous group

 

Interventions

Inpatient multidisciplinary rehabilitation administered by experienced physical therapists, 60‐min session, 6 days/week for 4 consecutive weeks, which included passive/assisted stretching exercises, strengthening exercises, balance exercises, ground‐floor walking (including step control), and 4 weeks of speech therapy (individual 60‐min sessions, once daily, 6 days/week) when aphasia was diagnosed

Outcomes

Sitting balance, standing balance, Hauser Index: gait disorders, MGHFAC: severity of gait disorders, FIM

Assessment time points

Before and after the intervention

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear

Free of selective reporting: Yes

Other bias:

  • Study design: case‐control study

  • Intervention did not include input from other disciplines, apart from speech pathologists. Also unclear if all the participants in the intervention group and control group received a similar programme

  • No sample size calculation performed

Quality rating of the study

Very low

Fu 2010

Methods

Retrospective case‐control study, USA

Participants

N = 42; Intervention: N = 21 with low‐grade gliomas, control: N = 21 with high‐grade gliomas

 

Inclusion: all patients admitted to an inpatient acute rehabilitation programme between 1996 and 2008. 21 of 443 with high‐grade and 21 of 24 with low‐grade astrocytoma were selected

Intervention

Inpatient multidisciplinary rehabilitation (details not provided)

Outcomes

FIM; LOS; discharge‐to‐home rate

Assessment time points

Admission and discharge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: N/A

Free of selective reporting: Yes

Other bias:

  • Study design: retrospective (medical records) case‐control

  • Contents, duration, and nature of multidisciplinary rehabilitation programme not described

  • Unclear selection criteria. Selected patients reported to have "adequate medical records", with the implication that patients who were not selected may not have had "adequate medical records"

Quality rating of the study

Very low

Geler‐Kulcu 2009

Methods

Case‐control study, Turkey

Participants

N = 42; Intervention: N = 21 with brain tumours (benign and malignant), control: N = 21 with stroke

 

Inclusion: all admitted patients to an inpatient neurorehabilitation unit, control participants were stroke patients (ischaemic or haemorrhagic), matched by side of lesion

Exclusion: people with oligoastrocytoma, oligodendroglioma, and ependymomas in order to obtain homogenous group

Interventions

Inpatient "conventional" rehabilitation programme, single 60‐min sessions, 5 days/week for 4 consecutive weeks, which included physiotherapy and occupational therapy (if needed). Physiotherapy focused on positioning, postural control, range of motion, and progressive resistive exercises together with endurance and gait. Patients were discharged when their functional level was considered sufficient to allow them to participate in outpatient rehabilitation

Outcomes

PAS for Stroke, BBS, MAS, FIM (mobility)

Assessment time points

Admission and discharge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear 

Free of selective reporting: Yes

Other bias:

  • Study design: case‐control study

  • Intervention not adequately described and did not include input from other disciplines apart from PT and OT

  • No sample size calculation performed

Quality rating of the study

Very low

Greenberg 2006

Methods

Retrospective case‐control study, Israel

Participants

N = 1828; Intervention N = 168  with brain tumours (128 meningiomas, 40 gliomas), control: N = 1660 with stroke (ischaemic or haemorrhagic)

 

Inclusion: all admitted patients to an inpatient neurorehabilitation unit over an 11‐year period (1993‐2004)

 

Interventions

Inpatient multidisciplinary rehabilitation provided by PT, medical staff, OT, and speech pathologist. Details of the multidisciplinary rehabilitation not provided

Outcomes

FIM, FIM efficiency, LOS days, discharge destination (rate discharge to home)

Assessment time points

Admission and discharge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: No

Free of selective reporting: Yes

Other bias:

  • Study design: retrospective, case‐control, compared with unmatched control cohort

  • Contents, duration, and nature of multidisciplinary rehabilitation not clearly defined

  • No sample size calculation performed

Quality rating of the study

Very low

Huang 2001a

Methods

Prospective case series, USA

Participants

N = 10 (brain tumour)

 

Inclusion: all admitted patients to an inpatient neurorehabilitation unit over a 1‐year period (1999‐2000)

Interventions

Inpatient multidisciplinary rehabilitation that included: OT, rehabilitation therapy, recreational therapy, speech therapy, PT, rehabilitation nursing and case management

Outcomes

FIM, DRS, KPS, FACT‐BR

Assessment time points

Admission and discharge, post hoc analysis at 3‐month postdischarge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear

Free of selective reporting: Yes

Other bias:

  • Study design: case‐series study, no control group

  • Contents, duration, and nature of multidisciplinary rehabilitation not clearly defined

  • Small sample size

Quality rating of the study

Very low

Huang 2000

Methods

Retrospective case‐control, USA

Participants

N = 156; Intervention: N = 78 with primary or metastatic brain tumours (benign and malignant), control: N = 78 with traumatic brain injury matched by age and side of lesion

 

Inclusion: evaluation by a physiatrist for the following criteria: medical stability, need for therapy from more than one discipline, demonstration of gains with acute‐care therapies, potential to tolerate 3 hours of therapy, willingness and motivation to participate in a rehabilitation programme

Exclusion: patients who did not complete rehabilitation due to medical complications or death

Intervention

Inpatient multidisciplinary rehabilitation (details not provided)

Outcomes

FIM; FIM efficiency; LOS; discharge destination to community rate

Assessment time points

Admission and discharge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear

Free of selective reporting: Yes

Other bias:

  • Study design: retrospective case‐control

  • Contents, duration, and nature of multidisciplinary rehabilitation not clearly defined

  • Unclear selection criteria: medically stable, motivated, and interested candidates only were selected by a single physiatrist for multidisciplinary rehabilitation with support arrangements for discharge to the community

Quality rating of the study

Very low

Huang 1998

Methods

Retrospective case‐control study, USA

Participants

N = 126; Intervention: N = 63 with primary or metastatic brain tumours (benign and malignant), control: N = 63 with stroke, case matched by age, gender, and side of lesion

 

Inclusion: all patients admitted to an inpatient rehabilitation centre

Intervention

Inpatient multidisciplinary rehabilitation (details not provided)

Outcomes

FIM; FIM efficiency; LOS; discharge destination to community rate

Assessment time points

Admission and discharge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear

Free of selective reporting: Yes

Other bias:

  • Study design: retrospective case‐control study

  • Contents, duration, and nature of multidisciplinary rehabilitation not clearly defined

Quality rating of the study

Very low

Kim 2012

Methods

Cohort study without control, Korea

Participants

N = 25 with brain tumours

Inclusion: all admitted patients to an inpatient neurorehabilitation unit after surgery (resection) for brain tumours (benign or malignant) over a 1‐year period (1 July 2008 to 30 June 2009), able to follow simple commands, as determined by scores ≥ 24 on the Korean version of the Mini‐Mental State Examination

Exclusion: those unable to complete a questionnaire because of a severe aphasia or a cognitive deficit, or who were clinically unstable, either medically or surgically

Interventions

Inpatient rehabilitation (4 weeks); details not provided

Outcomes

Fatigue severity: PFS, BFI

Mood status: BDI

Motor impairment: MI

Functional status: KPS, MBI

QoL: EORTC QLQ‐C30

Assessment time points

Before and after the intervention

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear

Free of selective reporting: Yes

Other bias:

  • Study design: cohort study without control group

  • Contents, duration, and nature of rehabilitation intervention not described

  • Small sample size and no sample size calculation

  • High dropout rate: 9/25 participants (36%)

Quality rating of the study

Very low

Marciniak 2001

Methods

Retrospective case series, USA

Participants

N = 132 participants divided into 4 groups: astrocytomas 26%, meningiomas 33%, metastatic tumours 16%, other tumours 25%. Participants also grouped into those with tumour recurrence and those with initial tumour presentation

 

Inclusion: all  patients > 18 years, inpatient rehabilitation within a 3‐year period (1993‐1996)

Intervention

Inpatient multidisciplinary rehabilitation (details not provided)

Outcomes

FIM; FIM efficiency; LOS; discharge destination to home rate

Assessment time points

Admission and discharge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear

Free of selective reporting: Yes

Other bias:

  • Study design: retrospective case series without control

  • Contents, duration, and nature of multidisciplinary rehabilitation not clearly defined

Quality rating of the study

Very low

O’Dell 1998

Methods

Retrospective case‐control, USA

Participants

N = 80; Intervention: N = 40 participants with brain tumours (benign and malignant), control: N = 40, case matched by admission FIM score, age, and gender to 40 participants with traumatic brain injury

 

Inclusion: all  patients admitted to an inpatient acute rehabilitation programme over a 2‐year period (1994‐1996)

Intervention

Inpatient multidisciplinary rehabilitation (details not provided)

Outcomes

FIM; LOS; discharge destination to home rate

Assessment time points

Admission and discharge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear

Free of selective reporting: Yes

Other bias:

  • Study design: retrospective case‐control

  • Contents, duration, and nature of multidisciplinary rehabilitation not clearly defined

Quality rating of the study

Very low

Pace 2007

Methods

Prospective case series (before and after) study, Italy

Participants

N = 121 with malignant brain tumours

 

Inclusion: all patients discharged from hospital over 3‐year period (2000‐2003) with neurological deficits

Intervention

Home neurorehabilitation programme including physiotherapy 1 hour/3 times a week for 3 months, neurologist evaluation, psychological assistance, nursing and palliative care team if needed (further details not provided)

Outcomes

BI, KPS, EORTC QLQ‐C30

Assessment time points

Before and 3 months after rehabilitation

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Patients who completed only basal questionnaire were excluded

Free of selective reporting: Yes

Other bias:

  • Study design: prospective before‐after study without control

  • Contents, duration, and nature of multidisciplinary rehabilitation (intervention) not clearly defined

Quality rating of the study

Very low

Sherer 1997

Methods

Retrospective case series, USA

Participants

N = 13 (primary malignant brain tumours with a history of surgical resection, radiation, and chemotherapy)

 

Inclusion: all patients receiving outpatient rehabilitation who had a diagnosis of malignant brain tumour and adequate medical records to characterise their tumour and courses of therapy

Intervention

Outpatient rehabilitation with input from psychologists, speech/language pathologists, OT, and vocational specialists. Participants received an average of 2.6 ± 1.9 months of therapy (duration of 5 hours/day) (further details not provided)

Outcomes

Level of independence, vocational (productivity) outcomes

Assessment time points

Admission, discharge, and 8‐months follow‐up

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Yes

Free of selective reporting: Yes

Other bias:

  • Study design: retrospective case series without control

  • Contents, duration, and nature of multidisciplinary rehabilitation not clearly defined

  • Small sample size

  • No validated measures used

Quality rating of the study

Very low

Tang 2008

Methods

Retrospective case series, Canada

Participants

N = 63 with primary and metastatic brain tumours, divided into 3 groups: glioblastoma multiforme 29%; metastatic tumours 40%; and various other primary brain tumours 31%

 

Inclusion: all patients admitted to an inpatient rehabilitation ward over a 3‐year period (2003‐2006)

Exclusion: patients with meningiomas

Intervention

Inpatient multidisciplinary rehabilitation (details not provided)

Outcomes

FIM; FIM efficiency; LOS; discharge destination to home rate; survival

Assessment time points

Admission and discharge

Risk of bias

Adequate sequence generation: No

Adequate allocation concealment: No

Blinding: No

Incomplete outcome data addressed: Unclear

Free of selective reporting: Yes

Other bias:

  • Study design: retrospective case series without control

  • Contents, duration, and nature of multidisciplinary rehabilitation not clearly defined

Quality rating of the study

Very low

BBS: Berg Balance Scale
BDI: Beck Depression Inventory
BFI: Brief Fatigue Inventory
BI: Barthel Index
DRS: Disability Rating Scale
EORTC QLQ‐C30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30
FACT‐BR: Functional Assessment of Cancer Therapy–Brain
FIM: Functional Independence Measure
KPS: Karnofsky Performance Status Scale
LOS: length of stay
MAS: Motor Assessment Scale
MBI: Modified Barthel Index
MGHFAC: Massachusetts General Hospital Functional Ambulation Classification
MI: Motricity Index
N: total number
N/A: not applicable
OT: occupational therapist
PAS: Postural Assessment Scale
PFS: Piper Fatigue Scale
PT: physiotherapist
QoL: quality of life
USA: United States of America

Figuras y tablas -
Table 1. Characteristics of observational studies
Table 2. Results of observational studies

Bartolo 2012

Statistical analysis

Student’s t test, Chi2 test,  Wilcoxon matched‐pairs signed‐rank test, Mann‐Whitney U test, Kruskal–Wallis ANOVA

Results

  • All the measures of outcome (FIM: mobility, ADL, cognition; balance tests, MGHFAC) were indicative of substantial improvements for brain tumour and stroke patients (P = 0.000 for all).

  • The values of functional gain in all scores were comparable between brain tumour and stroke groups.

  • Analysis of subgroups showed that people affected by meningioma achieved better results (in efficiency terms) as regards independence in ADL (P = 0.02) and mobility (P = 0.04) compared with people affected by glioblastoma or stroke.

  • No statistically significant differences were found on other clinical scales.

Author’s conclusions

Rehabilitation after surgery can improve functional outcome, justifying the delivery of rehabilitation services, even during the acute phase, to brain tumour inpatients, irrespective of tumour type

Fu 2010

Statistical analysis

Descriptive analysis, Chi2 test, Kruskal‐Wallis test, Mann‐Whitney U test

Results

  • Both groups made statistically significant functional gains in their total FIM scores, ADL, and mobility FIM score from admission to discharge (P < 0.05 for all).

  • Significantly greater gains were noted in high‐grade astrocytoma for total FIM (22 vs. 13, P = 0.02) and cognition FIM subscores (4.6 vs. 1.7, P = 0.04) compared with low‐grade astrocytoma.

  • FIM efficiency was comparable between groups (1.9 high‐grade astrocytoma vs. 1.8 low‐grade astrocytoma, P = 0.8).

  • Mean length of stay in the rehabilitation unit for people with high‐grade astrocytoma was significantly longer than for low‐grade (13 vs. 9 days, P = 0.04).

  • Discharge to home rate was also comparable between groups: 90% in both groups.

Author’s conclusion

All participants made significant functional gains from admission to discharge. Compared with people with low‐grade astrocytoma, people with high‐grade astrocytoma had higher total FIM gain but also longer LOS. FIM efficiencies were comparable between the groups

Geler‐Kulcu 2009

Statistical analysis

Freidman test, Chi2 test, Mann‐Whitney U test, ANOVA

Results

  • Both groups improved significantly in terms of PASS, BBS, MAS, and FIM mobility scores (all P < 0.05).

  • There was no statistically significant difference between the two groups with respect to any of the four outcome measures.

  • There was no statistically significant difference between the groups in any of the four outcome measures when compared between people with different forms of brain tumours and people with stroke.

Author’s conclusions

People with brain tumour progressed as well as people with stroke in a post‐acute inpatient rehabilitation programme

Greenberg 2006

Statistical analysis

Descriptive statistics, analysis of variance

Results

  • Functional variables during inpatient multidisciplinary rehabilitation were found to be similar in all the groups: average FIM rating at admission was 80.07 in the meningioma group, 68.2 in the glioma group, and 70.4 in the stroke group (P = 0.16); average discharge FIM rating was 90.3 for people with meningiomas, 80.7 for people with gliomas, and 87.8 for people with stroke (P = 0.76).

  • There was no significant difference in functional gain among groups: functional gain was 17.9 for people with meningioma, 17.2 for people with glioma, and 21.8 for people with stroke (P = 0.4).

  • FIM efficiency analysis showed that both brain tumour groups had similar efficacy and that people with stroke had the lowest efficiency (P = 0.001).

  • Average LOS was 24 days for the meningioma group, 23 days for the glioma group, and 75.4 days for the stroke group.

  • 88.1% of people with stroke, 91.7% of people with meningioma, and 82.7% of people with glioma were discharged to their homes, and 5.4%, 3.4%, and 8.6%, respectively, were discharged to nursing homes.

Author’s conclusions

Both people with gliomas and people with meningiomas hospitalised for inpatient rehabilitation improved their FIM ratings after a short inpatient multidisciplinary rehabilitation. Both groups had high rates of discharge to the community

Huang 2001a

Statistical analysis

ANOVA, Spearman’s correlation analysis, Bonferroni statistical test

Results

  • Improvement in total functional outcome was indicated by all 3 functional measures (FIM: P < 0.05; DRS: P < 0.05; KPS: P < 0.05).

  • Significant improvements were found between admission and discharge scores for the FIM and DRS.

  • KPS revealed significant improvement between admission and 3‐months follow‐up scores.

  • All admission and discharge functional scales (FIM, DRS, KPS) correlated significantly with each other.

  • No significant change was noted in the FACT‐BR between admission and discharge scores, but FACT‐BR scores did improve at 1‐ and 3‐months postdischarge relative to admission.

  • FIM, KPS, and DRS did not show significant correlation with FACT‐BR.

  • 90% of participants were initially discharged to a home environment.

Author’s conclusion

Although participants made functional gains during and after inpatient multidisciplinary rehabilitation, gains in QoL were not significant until 1‐month postdischarge. QoL does not appear to correlate well with functional outcomes. Furthermore, the KPS is less sensitive than the FIM and DRS in detecting change in functional status

Huang 2000

Statistical analysis

ANOVA, Chi2 test

Results

  • Both groups improved significantly for FIM score at discharge (P < 0.01).

  • Change in FIM score was significantly greater in the traumatic brain injury group for total FIM score (P < 0.01), ADL FIM score (P < 0.01), and mobility FIM score (P < 0.01).

  • No differences were noted for change in cognitive FIM between groups (P = 0.06).

  • FIM efficiency was similar between groups (FIM change per week: 10 tumour vs. 11.3 traumatic brain injury, P = 0.3).

  • LOS was significantly shorter in tumour group (22 days vs. 32 days, P < 0.01).

  • Discharge community rate was significantly greater in tumour group (87%) vs. traumatic brain injury group (74%) (P < 0.05).

Author’s conclusion

People with brain tumour can achieve comparable functional outcome and have a shorter rehabilitation length of stay and greater discharge to community rate than people with traumatic brain injury

Huang 1998

Statistical analysis

ANOVA, Chi2 test

Results

  • Both groups improved significantly for FIM score at discharge.

  • FIM change was comparable between groups (23.6 brain tumour vs. 29.1 stroke, P = 0.08)

  • Change in ADL FIM score was significantly greater in stroke group (10.8 vs. 8.3, P = 0.03). No differences were noted for change in motor and cognitive FIM between groups.

  • FIM efficiency was comparable between groups (FIM change/week: 8.4 brain tumour vs. 7.2 stroke, P = 0.29).

  • LOS was significantly shorter in brain tumour group (25 days vs. 34 days, P < 0.01).

  • Discharge to community rate was comparable between groups (86% for brain tumour vs. 94% for stroke) (P = 0.06).

Author’s conclusion

People with brain tumour can achieve comparable functional outcome and discharge to community rate, and have a shorter rehabilitation length of stay than people with stroke

Kim 2012

Statistical analysis

Mann–Whitney test, Spearman’s correlation analysis, Wilcoxon signed‐rank tests

Results

  • Fatigue correlated significantly with the KPS, MBI, and EORTC QLQ‐C30 physical functioning and insomnia scales.

  • Insomnia was a significant predictor of fatigue before rehabilitation (P = 0.004).

  • Baseline fatigue scales, MBI, MI, and EORTC QLQ‐C30 physical functioning scale were the important independent predictors of fatigue after rehabilitation.

  • After 4 weeks rehabilitation, there was significant improvement in KPS (50.0 ± 11.5 vs. 59.4 ± 13.4, P = 0.04), MBI (47.2 ± 27.0 vs. 72.2 ± 28.1, P < 0.01), MI (56.2 ± 20.6 vs. 63.4 ± 14.0, P < 0.01), whereas total PFS and BFI scores did not change.

  • Participants with a moderate level of fatigue showed significant improvement in the PFS (5.2 ± 0.5 vs. 3.1 ± 1.6, P = 0.02), KPS (47.1 ± 9.5 vs. 64.3 ± 11.3, P = 0.02), MBI (45.7 ± 28.8 vs. 69.1 ± 37.8, P = 0.04), MI scores (64.1 ± 11.7 vs. 70.6 ± 9.2, P = 0.03), and participants with a mild level of fatigue significantly improved in the MBI score (56.3 ± 29.6 vs. 77.9 ± 24.4, P = 0.04).

Author’s conclusion

The findings suggest that people with brain tumours commonly complain of a moderate level of fatigue, which may reduce daily functioning and quality of life, with sleep disturbance being a significant predictor of fatigue. During rehabilitation, functional outcomes and motor power showed improvements in those people, not aggravating fatigue

Marciniak 2001

Statistical analysis

Descriptive analysis, analysis of variance

Results

  • All groups made significant functional gains in their FIM score, and motor and cognitive FIM subscores from admission to discharge.

  • Total FIM change was comparable between tumour groups.

  • The change in FIM motor subscores was significantly smaller for those with metastasis (8.6) and astrocytomas (16.2) when compared with meningiomas (20) and other tumours (21).

  • The tumour recurrence group had significantly lower motor FIM gains (13.4 vs. 21.4), and FIM efficiency (0.55 vs. 0.98), lower discharge motor FIM scores (50.1 vs. 63.1) compared to those receiving rehabilitation after initial tumour treatment.

  • Participants who received radiation during rehabilitation had significantly greater motor efficiency score (1 ± 0.79) than those who did not (P < 0.05).

  • Participants in the metastatic disease group had significantly shorter LOS than other tumour groups (P = 0.03).

  • Overall, 65% of the 132 admissions were discharged home. People with meningiomas were less likely to be discharged home (47%) than those with metastatic tumours (71%), astrocytic tumours (71%), or those in the other tumours group (79%) (P = 0.01).

Author’s conclusion

Metastatic or primary brain tumour type does not affect the efficiency of functional improvement during inpatient multidisciplinary rehabilitation. People receiving concurrent radiation therapy make greater functional improvement per day than those not receiving radiation. People with recurrent tumours make significantly smaller functional motor gains than those completing inpatient multidisciplinary rehabilitation after the initial diagnosis of the tumour

O’Dell 1998

Statistical analysis

Descriptive analysis, Chi2 test, Kruskal‐Wallis test, Mann‐Whitney U test

Results

  • Both groups made significant functional gains in their FIM scores: total FIM, ADL and mobility subscores from admission to discharge.

  • Total FIM change was significantly greater in the traumatic brain injury group compared to the brain tumour group (35 vs. 25, P < 0.02).

  • FIM efficiency was comparable between groups: 1.9 for traumatic brain injury vs. 1.5 for brain tumour.

  • LOS was comparable between groups: 22 days for traumatic brain injury vs. 18 days for brain tumour.

  • Discharge to home rate was also comparable between groups: 93% for traumatic brain injury vs. 83% for brain tumour.

Author’s conclusion

Daily functional gains made by people with brain tumour undergoing multidisciplinary rehabilitation were similar to those made by people with traumatic brain injury matched by age, gender, and admission functional status

Pace 2007

Statistical analysis

 Chi2 test, Student t test (paired or not, as appropriate)

Results

At 3‐months follow‐up:

  • BI improved in 47 participants (39%), was stable in 20 (16%), and worsened in 54 (44%).

  • In those with clinical improvement, BI score increased significantly from baseline (median 15 points, P < 0.001).

  • KPS scores were better in only 24% of participants by median 10 points (P < 0.001).

  • No significant difference was observed between various subgroups of brain tumour and between those with initial diagnosis and those treated for reoccurrence.

  • Only 54 participants completed the QoL questionnaire before and after treatment: 72% were found to have an improvement in at least one domain score compared with their baseline QoL scores.

  • In those with improved BI scores, physical and social scores increased in 67%, emotional functional score increased in 39%, and global QoL score increased in 44%.

Author’s conclusion

Multidisciplinary rehabilitation at home in people with brain tumour was associated with significant functional gain measured both with BI and KPS. The benefit of multidisciplinary rehabilitation may influence patient's perception of quality of life

Sherer 1997

Statistical analysis

Descriptive analyses only

Results

  • At the time of discharge from the programme, 6 participants had increased independence, 6 were unchanged, and 1 had decreased independence.

  • At discharge, 8 participants had increased productivity (increased/improved/maintained the previous vocational status), 4 were unchanged, and 1 had decreased productivity.

  • At 8‐months follow‐up after discharge all the treatment gains were maintained. At follow‐up, compared with admission status, 7 participants had increased independence, 4 were unchanged, 1 had decreased independence, and 1 had died.

Author’s conclusion

People with primary malignant brain tumours achieved increased community independence and vocational outcomes (such as employment, education) after individualised outpatient multidisciplinary rehabilitation. Such treatment programme appears to be an attractive, relatively low‐cost option for these patients, however additional investigation is needed.

Tang 2008

Statistical analysis

ANOVA, Chi2 test, Kruskal‐Wallis and post‐hoc tests using Mann‐Whitney U test with Bonferroni adjustment, Wilcoxon signed‐ranks test, logistic regression, Kaplan‐Meier analyses

Results

  • All groups made significant improvement in their FIM scores from admission to discharge. Motor FIM, but not cognitive FIM scores, improved significantly in all 3 groups.

  • FIM efficiency was comparable between groups (0.33 GBM, 0.4 metastatic, 0.2 other).

  • None of the independent variables (age, length of rehabilitation, concurrent radiation therapy, concurrent chemotherapy, type of tumour, hemispheric location, or number of brain lesions) were significant predictors of high or low FIM gain for all people with brain tumours.

  • Discharge‐to‐home rate was comparable between groups (76% GBM, 72% metastatic, 70% other).

  • Estimated median survival was 141 days for brain metastases, 214 days for GBM, and 439 days for other tumours.

Author’s conclusion

People with primary and metastatic brain tumours achieved functional gains after multidisciplinary rehabilitation. High functional improvement is a significant predictor of longer survival in brain metastases and GBM.

ADL: activities of daily living
ANOVA: analysis of variance
BBS: Berg Balance Scale
BFI: Brief Fatigue Inventory
BI: Barthel Index
DRS: Disability Rating Scale
EORTC QLQ‐C30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30
FACT‐BR: Functional Assessment of Cancer Therapy–Brain
FIM: Functional Independence Measure
GBM: glioblastoma multiforme
KPS: Karnofsky Performance Status Scale
LOS: length of stay
MAS: Motor Assessment Scale
MBI: Modified Barthel Index
MGHFAC: Massachusetts General Hospital Functional Ambulation Classification
MI: Motricity Index
OT: occupational therapist
PASS: Postural Assessment Scale for Stroke
PFS: Piper Fatigue Scale
PT: physiotherapist
QoL: quality of life
USA: United States of America

Figuras y tablas -
Table 2. Results of observational studies